HD-OPM Archive
Topics › Inflammation & CRP

Methotrexate may lower heart disease risk in rheumatoid arthritis and be safer than NSAIDs

Louis Nervegna · Oct 19, 2025 · ♥ 5 reactions · 4 comments · original Facebook post
Inflammation & CRPHeart attack, stroke & proceduresKidney health
AI summary & key facts

Louis says methotrexate has an undeserved bad reputation and newer research suggests it may reduce cardiovascular risk in people with rheumatoid arthritis or other inflammatory diseases. He notes long-term NSAIDs, especially Cox-2 inhibitors, raise heart attack and stroke risk and are hard on the kidneys, and advises talking to a cardiologist. No specific study is cited.

Methotrexate is a drug that has gotten a bad rap over the years.

But newer research is showing that it may lower the risk of heart disease in patients with rheumatoid arthritis or other inflamnatory diseases.

It may be a safer option than Cox-2 inhibitors and other NSAIDS in people with both heart disease and rheumatoid arthritis. These NSAID drugs are known to increase risk of heart attacks and strokes when used long term (particularly the Cox-2 inhibitors). They are also tough on the kidneys.

Talk to your cardiologist.

#methotrexateHD #rheumatoidarthritisHD #nsaidsHD #cox2inhibitorsHD #arthritisHD #kidneysHD

← newer: Nature: tools to edit mitochondrial DNA are emerging, relevaolder: Meta-analysis: statin use linked to 20% lower dementia and 3 →